Multiple Sclerosis and Related Disorders

Scope & Guideline

Unraveling the complexities of multiple sclerosis and beyond.

Introduction

Immerse yourself in the scholarly insights of Multiple Sclerosis and Related Disorders with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2211-0348
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2012 to 2024
AbbreviationMULT SCLER RELAT DIS / Mult. Scler. Relat. Disord.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'Multiple Sclerosis and Related Disorders' focuses on advancing the understanding of multiple sclerosis (MS) and related conditions through innovative research and clinical studies. Its core aims are to provide a platform for disseminating high-quality research that addresses various aspects of MS, including its pathophysiology, treatment, and patient care.
  1. Clinical and Epidemiological Research:
    The journal emphasizes studies that explore the clinical characteristics, epidemiology, and natural history of multiple sclerosis, providing valuable insights into the disease's progression and factors influencing its course.
  2. Therapeutic Advances and Treatment Protocols:
    It covers research on the efficacy and safety of disease-modifying therapies (DMTs) and other treatment modalities, including novel therapies, their impact on quality of life, and management strategies for MS and related disorders.
  3. Neuroimmunology and Pathophysiology:
    Research on the underlying immunological mechanisms and neurobiological changes associated with MS is a key focus, aiming to enhance understanding of disease mechanisms and identify potential therapeutic targets.
  4. Patient-Reported Outcomes and Quality of Life:
    The journal prioritizes studies that assess patient-reported outcomes, including quality of life, mental health, and the psychosocial impacts of living with MS, emphasizing a holistic approach to patient care.
  5. Innovative Diagnostic Techniques:
    Research exploring advanced diagnostic tools and biomarkers for MS, including imaging techniques and laboratory assays, is highlighted to improve diagnostic accuracy and patient stratification.
  6. Multidisciplinary Approaches to Care:
    The journal promotes studies that investigate the effectiveness of multidisciplinary care models, including rehabilitation, physical therapy, and psychological support for MS patients.
The journal has seen significant growth in specific research themes that reflect current trends and emerging interests in the field of multiple sclerosis. This section outlines these trending areas, showcasing their relevance and potential impact on future research and clinical practice.
  1. Impact of COVID-19 on MS Patients:
    Research exploring the effects of COVID-19 on MS patients, including vaccine responses and disease management during the pandemic, has surged, reflecting the urgency of understanding this intersection.
  2. Telemedicine and Remote Care Models:
    There is a growing emphasis on studies evaluating telehealth interventions and their effectiveness in managing MS, driven by the need for accessible care during the pandemic.
  3. Neuropsychological and Cognitive Function Studies:
    Increased attention is being given to the assessment and management of cognitive impairment in MS patients, focusing on innovative interventions and understanding the neuropsychological aspects of the disease.
  4. Patient-Centered Care and Shared Decision-Making:
    Research highlighting the importance of patient perspectives, shared decision-making, and personalized care approaches is gaining traction, indicating a shift towards more holistic and inclusive treatment strategies.
  5. Biomarkers and Predictive Modeling:
    Emerging studies focusing on biomarkers, such as neurofilament light chains, and their role in predicting disease progression and treatment response are trending, reflecting advancements in precision medicine.
  6. Lifestyle Interventions and Holistic Approaches:
    There is an upward trend in research examining the impact of lifestyle factors, including diet and exercise, on MS symptom management and overall health outcomes, emphasizing a comprehensive approach to care.

Declining or Waning

While 'Multiple Sclerosis and Related Disorders' has maintained a broad focus, certain areas have seen a decline in emphasis in recent years. This section identifies these waning scopes, reflecting shifts in research priorities and emerging interests.
  1. Basic Science Research:
    There appears to be a declining focus on basic science studies that explore fundamental biological mechanisms of MS, as the journal increasingly prioritizes clinical and translational research.
  2. Historical Epidemiological Studies:
    Research focusing solely on historical epidemiological trends without contemporary relevance may be waning, as the journal shifts towards studies that provide actionable insights for current clinical practice.
  3. Single-Disorder Focus:
    There is a noticeable reduction in publications that focus exclusively on multiple sclerosis, with a growing trend towards comparative studies involving related disorders, such as neuromyelitis optica spectrum disorders.
  4. Pharmacovigilance Studies without Clinical Implications:
    Studies that examine adverse drug reactions in isolation, without linking findings to clinical outcomes or treatment strategies, have become less common.

Similar Journals

ACTA NEUROLOGICA SCANDINAVICA

Pioneering Research in Neurology
Publisher: WILEYISSN: 0001-6314Frequency: 12 issues/year

ACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.

CURRENT OPINION IN NEUROLOGY

Uncovering Breakthroughs in Neurological Research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1350-7540Frequency: 6 issues/year

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.

Neurology Research International

Empowering Neurological Discovery and Dialogue
Publisher: HINDAWI LTDISSN: 2090-1852Frequency:

Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Exploring the Frontiers of Neurological Science
Publisher: CAMBRIDGE UNIV PRESSISSN: 0317-1671Frequency: 6 issues/year

Canadian Journal of Neurological Sciences, published by Cambridge University Press, stands as a reputable source of knowledge in the field of neurology, dedicated to advancing research and clinical practice. With an ISSN of 0317-1671 and an E-ISSN of 2057-0155, this journal has been a cornerstone for the exchange of ideas since its inception in 1974 and will continue to cater to the academic community until 2024. Recognized in the top quartile (Q2) in various categories including Medicine (miscellaneous) and Neurology (clinical), its articles engage a broad audience, ranging from established researchers to students seeking to deepen their understanding of neurological sciences. Although the journal is not an open-access publication, it provides vital insights and research findings that contribute significantly to its fields. With a Scopus rank of #183 in clinical neurology and a percentile ranking that reflects its commendable standing, the Canadian Journal of Neurological Sciences is indispensable for those committed to the exploration and treatment of neurological disorders.

Multiple Sclerosis Journal

Catalyzing Change Through Groundbreaking Research
Publisher: SAGE PUBLICATIONS LTDISSN: 1352-4585Frequency: 14 issues/year

Multiple Sclerosis Journal, published by SAGE Publications Ltd, is a leading academic journal in the fields of neurology and clinical neurology, with an impressive impact factor reflecting its critical role in neurological research. Established in 1995 and continuing to 2024, this journal has positioned itself as a premier platform for disseminating innovative and impactful research related to multiple sclerosis, thereby contributing significantly to both clinical practice and scientific advancements in the field. The journal's robust standing is evidenced by its Q1 category rankings, placing it in the top tier of both Neuroscience (Rank #16/192, 91st Percentile) and Clinical Neurology (Rank #35/400, 91st Percentile) categories, making it an essential resource for researchers, healthcare professionals, and students alike. The journal focuses on a wide array of topics, including basic research, clinical trials, and treatment methodologies, ensuring that its readership is well-informed about the latest developments and trends. Access to its articles is through subscription, fostering a reputable environment for quality research dissemination.

Turkish Journal of Neurology

Illuminating the path to neurological advancements.
Publisher: GALENOS PUBL HOUSEISSN: 1301-062XFrequency: 4 issues/year

Turkish Journal of Neurology, published by GALENOS PUBL HOUSE, is a pivotal open-access journal established in 2004, dedicated to advancing the field of neurology. Renowned for its inclusive approach, this journal serves as a vital platform for researchers and clinicians to share their findings and insights related to neurological disorders and clinical practices, with an emphasis on enhancing the understanding of various neurological conditions affecting populations in Turkey and beyond. Although it holds a Q4 rank in Neurology (Clinical) as per the 2023 category quartiles, the journal's commitment to fostering knowledge exchange remains steadfast, aiming to bridge gaps in clinical research and practice. With an ISSN of 1301-062X and an E-ISSN of 1309-2545, it is indexed in Scopus, ranking 349 out of 400, reflecting its growing presence in the academic sphere. Located in Istanbul, Turkey, the journal invites submissions from both emerging and established researchers to contribute to its diverse content, thereby enhancing its impact on the local and international neurology community.

REVUE NEUROLOGIQUE

Advancing Neurological Science with Every Issue
Publisher: MASSON EDITEURISSN: 0035-3787Frequency: 10 issues/year

REVUE NEUROLOGIQUE, published by MASSON EDITEUR, is a prestigious academic journal that plays an essential role in the field of neurology. With a rich history spanning from 1946 to the present, this journal focuses on both foundational and clinical aspects of neurology, underscoring its significance within the medical community. Holding an impressive Q2 ranking in both general and clinical neurology categories as of 2023, REVUE NEUROLOGIQUE is recognized for its contribution to advancing neurological science, as evidenced by its Scopus rankings, with a notable position in the 62nd percentile for clinical neurology. The journal fosters an environment for rigorous research and is instrumental for professionals and scholars aiming to stay abreast of the latest developments in neurological disorders and treatments. Although it is not an open-access publication, it offers a wealth of vital research through its issues, appealing to those engaged in both clinical practice and academic research in neurology.

NEUROLOGIST

Cultivating Excellence in Neurology and Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1074-7931Frequency: 6 issues/year

NEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.

Current Journal of Neurology

Innovating research for a brighter neurological future.
Publisher: TEHRAN UNIV MEDICAL SCIENCESISSN: 2717-011XFrequency: 4 issues/year

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

Archives of Neuroscience

Exploring the depths of brain function and disorders.
Publisher: BRIEFLANDISSN: 2322-3944Frequency: 4 issues/year

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.